About Pamplona Therapeutics (HK) Limited
Pamplona Therapeutics (HK) LimitedPamplona Therapeutics is an early-stage drug discovery company developing targeted protein degradation (TPD) therapy to address unmet needs in autoimmune and oncology diseases. The company has built a cutting-edge, AI-driven TPD drug discovery platform (ASTRIDE®) that integrates target structure prediction, high-throughput virtual screening, molecular docking, molecule generation, and ubiquitination assessment modules.






